AXSM vs ECL · rev $385.7M vs P/E 35, rev $4.01B
Axsome Therapeutics Inc (AXSM) versus Ecolab Inc (ECL) — a side-by-side from cached financials, not a winner call.
Axsome Therapeutics Inc (AXSM) is a biotechnology company listed on US.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Latest reported AXSM revenue for 2024-12-31 was $385.7M. Net income was -$287.2M. Revenue was up 42.5% from 2023-12-31 to 2024-12-31. AXSM currently screens at market cap $11.96B.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
AXSM currently screens at market cap $11.96B. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Not investment advice. Open the AXSM and ECL stock pages for the full models.
Not investment advice.